Express News | Kiromic Biopharma Inc - Patient 4 Shows 5.3% Tumor Reduction at Six-Month Follow-up

ReutersOct 8 08:00 ET

Express News | Kiromic Biopharma Inc - Additional Follow-up Results Expected in October

ReutersOct 1 08:03 ET

Express News | Kiromic Biopharma Inc - Progression-Free Survival Reaches 10 Months With No Adverse Events

ReutersOct 1 08:03 ET

Kiromic BioPharma Reports Favorable 10-Month Follow-Up Results for the First Patient Treated in Its Deltacel-01 Clinical Trial

BusinesswireOct 1 08:00 ET

Kiromic BioPharma Activates the University of Arizona Cancer Center as the Fifth Clinical Trial Site in the Ongoing Phase 1 Deltacel-01 Trial

BusinesswireSep 19 16:30 ET

Express News | Kiromic Biopharma Activates the University of Arizona Cancer Center as the Fifth Clinical Trial Site in the Ongoing Phase 1 Deltacel-01 Trial

ReutersSep 19 16:30 ET